close
close

INDUSTRY: Patient on the Rhine

INDUSTRY: Patient on the Rhine

The Bayer-Konzern has run into major problems: The Aktienkurs are in Talfahrt, we continue with the Geduld, and in the USA we continue with Milliarden-Klagen. Reichen die Rezepte von Vorstandschef Bil …